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Human platelets loaded with the fluorescent Ca2+ indicator quin2 and with different radioactive 
compounds including [3H]serotonin, [14C]arachidonic acid (AA) and [32P]orthophosphate were stimulated 
by thrombin under conditions producing secretion. In the absence of external Ca2’ (Gag’), cytoplasmic 
free [Ca2’], [Ca2+]i, increased to 340 nM, against 1685 nM at 1 mM [CaL+le. In both cases, diglyceride 
and phosphatidic acid production proceeded at the same rate, whereas AA release was inhibited at low 
[Ca’+]i. It is concluded that, at variance with phospholipase AZ, phospholipase C activation does not 
depend on [Ca2+]r. These results give further support o the hypothesis of a Ca2+-independent pathway 
of cell activation involving phospholipase C and protein kinase C. 
Platelet activation Thrombin Phospholipase C Inositol phospholipid Calcium 
Fluorescent indicator 
1. INTRODUCTION 
An increased turnover of inositol-phospholipids 
triggered by specific agonists able to mobilize 
calcium has been recognized as a widespread 
phenomenon accompanying the activation of a 
number of cells, including platelets [l-6]. Three 
fundamental advances were recently realized in 
this field: 
(i) Phosphodiesteratic leavage of PI-P2 occurs as 
one of the earliest events of cell activation and pro- 
motes the mobilization of intracellular calcium 
through the liberation of inositol-1,4,5-triphos- 
phate [7-91; 
(ii) DC, the other product of PLC action, are 
Abbreviations: PI, phosphatidylinositol; PI-P, phos- 
phatidylinositol Cphosphate; PI-P2, phosphatidylinosi- 
to1 4,5-bisphosphate; DG, diglyceride; PA, phosphatidic 
acid; PLC, phospholipase C; [Ca”]i, cytoplasmic free 
calcium concentration; [Ca2+],, external free calcium 
concentration; PRP, platelet-rich plasma; AA, arachi- 
donic acid 
specific activators of protein kinase C [lo]. This 
leads, in platelets, to the phosphorylation of a 
40-kDa protein directly involved in secretion [ 111. 
The most recent evidence indicates that such a pro- 
cess occurs at [Ca”] as low as lo-’ M [ 1 I]. In con- 
trast, /cM [Ca”] are required to activate the cal- 
modulin-dependent myosin light chain kinase [ 1 I]. 
(iii) The use of the fluorescent calcium indicator, 
quin2, has enabled us to measure the cytoplasmic 
free calcium concentration [Ca’+]i in platelets 
under various conditions of stimulation [12]. It 
was found that thrombin can elevate [Ca’+]i to the 
micromolar range only if external calcium, [Ca’+],, 
is present. At zero [Ca2+le, [Ca2+]; increases only 
to 200-300 nM and this is still accompanied by a 
full secretory response. However, when such a 
small [Ca’+]i elevation is induced by ionophores, 
platelet activation no longer occurs. This has rais- 
ed the concept of a ‘Ca2+ -independent pathway’ of 
platelet activation involving DG and protein kinase 
C [12,13]. 
If this concept is correct, one has to admit that 
the activation of PLC, a Ca2+-dependent enzyme 
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[14-191, should also occur at basal [Ca”]i, just as 
described for protein kinase C. This study was thus 
undertaken with quin2 loaded platelets in order to 
check for phospholipase C activation upon throm- 
bin challenge under conditions where [Ca2+]i was 
monitored. 
2. MATERIALS AND METHODS 
Quin2 was obtained from the Radiochemical 
Centre (Amersham). [32P]orthophosphate was 
from C.E.A. (Saclay). [U-14C]AA (390 mCi/ 
mmol) and 5-[3H]hydroxytryptamine (serotonin, 
33.8 Ci/mmol) were purchased from NEN (Drei- 
eich). Human thrombin (3000 NIH units/mg pro- 
tein) and imipramine were from Sigma (St. Louis, 
MO). 
2.1. Preparation of platelets 
Fresh human blood from human volunteer 
donors not having taken any medication for at 
least a week was drawn onto acid citrate dextrose 
(ACD) as an anticoagulant [20]. PRP was obtained 
by centrifugation at 120 x g for 20 min (20°C). 
PRP was incubated at 37°C in the presence of 
15 PM quin2 (30 min), lOO,&i/ml [32P]ortho- 
phosphate (60 min), 1 &i/ml [‘Hlserotonin 
(30 min) or 0.15 &i/ml [t4C]AA (90 min). Quin2 
was added in all incubation procedures, whereas 
radioactive precursors were included alternatively. 
In all cases, the whole labelling time did not exceed 
90 min. Platelets were sedimented at 1000 x g for 
20 min and suspended in 0.5 vol. (compared to 
PRP) of a Tyrode-Hepes buffer (pH 7.35) lacking 
calcium [20]. Platelet concentration under these 
conditions was around 5 x lo* cells/ml. 
2.2. Incubation of platelets 
Platelet suspensions were equilibrated for 1 min 
at 30°C in 2 ml fluorimeter cuvettes. [Ca2+], was 
kept near zero or brought to 1 mM upon addition 
of 0.1 M CaClz. Thrombin (1 units/ml, final con- 
centration) or buffer (in controls) was added under 
a minimal volume (0.01 ml/ml suspension), fol- 
lowed by brief mixing using a plastic bar. Various 
experiments under identical conditions included 
determination of [Ca’+]i, of serotonin secretion 
and lipid studies. 
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2.3. Measurement of [Cd’], 
This was performed as in [12] using a Perkin 
Elmer spectrofluorimeter (model MPF-3 L). 
2.4. Determination of serotonin secretion 
Release of [3H]serotonin was assessed essentially 
as in [21] in the presence of 2pM imipramine in 
order to inhibit reuptake. 
2.5. Lipid studies 
Lipids were extracted as in [22] after acidifica- 
tion with 10 N HCI in the case of 32P-labelled 
phospholipids [23], or with formic acid when 
[14C]AA was used [24]. 32P-labelled lipids were 
isolated by monodimensional thin-layer chromato- 
graphy [25], which allowed a good separation of 
PI, PI-P, PI-P2 and PA. In the case of [14C]AA ex- 
periments, development was performed as in [26]. 
This system separated from the bulk of phospho- 
lipids, PA, various cycle-oxygenase and lipoxy- 
genase derivatives of AA, non-converted AA and 
DG. 
3. RESULTS 
As shown in fig.1, human platelets loaded with 
quin2 remained fully responsive to thrombin with 
respect to serotonin secretion. However, release 
proceeded faster with 1 mM [Ca”],. This dif- 
ference could be related to the variations of [Ca2+]i 
(fig.2). Starting from a basal concentration of 
140 nM in the resting state, [Ca2+]i ncreased to 
340 nM within 15 s, when [Ca”], was kept near 
zero. With 1 mM [Ca2+],, basal and maximal 
[Ca2+]i were 217 nM and 1685 nM, respectively. 
,/- 
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SECONDS 
Fig. 1. Time course of serotonin secretion from platelets 
stimulated by thrombin. Release is expressed as 
percentage of total platelet serotonin and corresponds to
the mean + SE (4 experiments); ** p < 0.02 according 
to Student’s l-test. 
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The latter concentration was reached within 30 s, 
but [Ca2+]i was already 1144 nM at 15 S. [Ca’+]i 
remained in the range of 250 nM at zero [Ca2’],, 
whereas it decreased progressively to 650 nM after 
2 min at 1 mM [Ca”],. 
0 30 60 90 120 
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Phospholipid changes occurring in 32P-labelled 
platelets are reported in fig.3. No major differences 
were observed in the three phosphoinositides, 
whatever [Ca”], was. The only significant varia- 
tion concerned PA, which appeared immediately 
after thrombin addition. After 1 min, it displayed 
a 320 and a 250% increase over controls, in the 
presence and absence of Ca’+,. However, dif- 
Fig.2. Variation of cytoplasmic free calcium 
concentration [Ca”]i during thrombin stimulation of 
human platelets. Values correspond to means + SE (5 
experiments). Probability of significance according to 
Student’s t-test: * p < 0.05; ** p < 0.02; *** p c 0.01. 
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Fig.3. Variation of phospholipid radioactivity in 32P- 
labelled platelets upon thrombin stimulation. Values 
(means k SE, 3 experiments) for controls (o---o) and 
thrombin-stimulated cells (M) are expressed in 
arbitrary units taking the radioactivity of PA at zero 
time as 1 unit [23]. Probability of significance according 
to Student’s t-test: ** p < 0.02; *** p < 0.01; **** p c 
0.001. 
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Fig.4. Formation of DG, PA, AA and its oxygenated 
derivatives in [r4C]AA-labelled platelets upon thrombin 
stimulation. Values (means + SE, 3 experiments) 
correspond to percentages of total radioactivity present 
in platelets; (o---o) [Ca”], = 0; (W) [Ca2+], = 
1 mM. Controls are not represented because they were 
essentially identical at zero and 60 s. Probability of 
significance according to Student’s t-test: * p < 0.05; 
** p < 0.02; ***p < 0.01. TXB2, thromboxane B2; 
HHT, 12-L-hydroxy-5,8,10-heptadecatrienoic acid; 
HETE, 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. 
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Table I 
Modifications of polyphosphoinositide radioactivity in thrombin-stimulated platelets 
May 1984 
Conditions Phospho~ip~ds No thrombin Plus thrombin Thromb~~-induced P 
decrease 
[Caz+lc = 0 PI-P2 6.9 rt: 1.0 5.5 i 0.8 1.4 z!z 0.4 < 0.02 
Pi-P 9.3 zt: 1.2 8.4 r?: I.1 1.0 It 0.3 < 0.05 
[Ca*+], = 1 mM PI-P2 4.6 + 0.6 4.4 I: 0.6 0.2 rt 0.1 NS 
PI-P 7.6 rt: 0.9 7.5 AZ 1.0 0.1 * 0.3 NS 
.~ _ 
Platelets foaded with quin2 and labelled with ~3zP~orthophospha~e were incubated for 10 s as described in the text. 
Radioactivity is expressed in arbitrary units as in 1231 and corresponds to the mean + SE (6 and 5 experiments in the 
absence and presence of Ca?‘, respectively). p, probability of significance according to paired Student’s f-test 
(differences were never significant when using the non-paired test) 
fefences between the two cases were not signifi- 
cant. 
As platelet PLC has been shown to selectively 
degrade PI-P2, we brought special attention to 
polyphosphoinositides in a series of experiments 
involving a 10 s incubation time. As reported in 
table 1, thrombin induced a 20 and IO% decrease 
of PI-P2 and PI-P, respectively, only when Ca? 
was omitted. In no case was any variation of PI 
observed (not shown). 
Phosphatidic acid production upon thrombin 
stimulation was also evidenced in ~~4C~~-IabeIled 
platelets and displayed the same characteristics 
(fig.4). But a transient DG increase couId also be 
detected under these conditions. As shown in tabfe 
2, DG displayed the same variation in the presence 
or absence of Caz’. 
Table 2 
Modifications of diglyceride radioactivity in thrombin- 
stimulated platelets 
Conditions Controls Assays P 
[Ca’+], = 0 0.30 2 0.07 0.67 + 0.06 <O.Ol 
[Ca”],= 1 mM 0.28 + 0.05 0.62 i 0.04 co.01 
Platelets loaded with quin2 and labelled with [‘4C]AA 
were incubated for 15 s in the absence or presence of 
thrombin. Values correspond to percentages of total 
radioactivity present in platelets and are means 4 SE of 
4 and 3 experiments in the absence and presence of 
Caf’, respectively. p, probability of significance 
according to Student’s t-test performed between controls 
and assays 
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In contrast, the release of AA and of its ox- 
ygenated derivatives displayed profound dif- 
ferences between the two cases, since the increase 
of radioactivity triggered by tbrombin was 7 times 
higher at 60 s for TXBz, HHT and HETE and 1.5 
times higher for AA when Cai* was present. 
4. DISCUSSION 
The main goa of this study was to check 
whether PLC activation in thrombin-stimuIated 
platelets can occur at basal &Za”]i under condi- 
tions similar to those allowing activation of protein 
kinase C. Taken together, our data indicate that 
this is indeed the case, since PA as well as DG are 
produced to the same level, whatever the extent of 
Ca2+ mobilization. Moreover, we also obtained 
evidence for a small PI-P2 and PI-P decrease upon 
thrombin stimulation in the absence of Ca?. 
However, this deerease was significant only when 
using the paired Student’s t-test. Such variations 
are difficult to evidence, since polyphosphoino- 
sitides are simultaneously degraded by phospho- 
diesteratie cleavage {?] and regenerated by PI 
phosphorylation @7,28]. Thus a PI-P2 decrease 
does not reflect quantitatively the extent of PLC 
activation and in this respect a great variability was 
found between different studies [7,27-301. This 
probably explains why such a decrease was no 
longer observed at 1 mM Caf’, whereas DG and 
PA production were essentiafly the same in both 
cases. 
In contrast, major differences were observed for 
the release of AA and eicosanoids. Two pathways 
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have been described for AA liberation from 
platelet phospholipids. One includes a Ca*+- 
dependent phospholipase A2 [31-331, whereas the 
other one involves the sequential action of PLC 
and DG-lipase [23,24], which is still controversial 
[35,36]. PLC remains active at very low [Ca”], 
(here), whereas DG-lipase is equally activated by 
Ca*+ and Mg*+ (Mauco, G. et al., in preparation), 
so that it should be fully active in the absence of 
Ca*+ mobilization. It would thus be tempting to 
speculate that phospholipase AZ was only active 
under conditions where [Ca*+]i was increased to 
micromolar concentrations, whereas the small 
release occurring at near basal [Ca*+]i could be the 
fact of PLC-DG-lipase. But further investigations 
are still required to determine the respective part of 
each pathway. 
In summary, our study brings evidence that 
platelet PLC activation occurs in the absence of a 
large Ca*+ mobilization. This is to our knowledge 
the first time that PLC activity was followed in 
parallel to [Ca*+]i determination. In a previous 
work dealing with in vitro measurement of PLC 
[15], we found an optimal [Ca”] of 1 mM for the 
enzyme, which still displayed a significant and 
almost constant activity between lo-’ and 10m6 M 
[Ca2’]. So our present study confirms and extends 
these data by showing that PLC activation occurs 
in vivo at basal [Ca2+]i, which appears to be suffi- 
cient for the enzyme to operate. In addition to our 
recent work on the properties of lysophosphatidic 
acids [37], this would give further support to the 
hypothesis that PLC together with protein kinase 
C are involved in cell activation through a Ca2+- 
independent pathway [l l-131. It also fits with the 
proposed role of inositol-tri-phosphate, the libera- 
tion of which by PLC would trigger Ca*+ mobiliza- 
tion from an intracellular store [9]. 
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